Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, Kabra Drugs has informed that the trading window shall remain closed from October 1, 2023 till 48 hours after announcement of the Unaudited Financial Results for the Quarter Ended 30th September, 2023. The date of Board Meeting will be informed in due course.
The above information is a part of company’s filings submitted to BSE.